Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 3/20 | 0.40 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL523729 | 0.87 | AR (0.46) | GPR35ARACHECYP3A4CACNA1G | |
| SCHEMBL16077413 | 0.81 | AR (0.42) | GPR35ARALDH1A1PGR | |
| SCHEMBL28929310 | 0.80 | ACHE (0.39) | ALDH1A1ACHECYP3A4 | |
| SCHEMBL27496792 | 0.80 | GPR35 (0.49) | GPR35ALDH1A1 | |
| SCHEMBL22030024 | 0.78 | SQOR (0.44) | GPR35ARALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL7664968 | 0.76 | ALDH1A1 (0.40) | ALDH1A1ACHECYP3A4 | |
| SCHEMBL509507 | 0.76 | ACHE (0.52) | GPR35ARALDH1A1ACHECYP1A2 | |
| SCHEMBL9127896 | 0.76 | ALDH1A1 (0.36) | ALDH1A1ACHECYP3A4 | |
| SCHEMBL2088423 | 0.76 | GPR35 (0.44) | GPR35ARTTRALBALDH1A1 | |
| SCHEMBL13480569 | 0.76 | GPR35 (0.41) | GPR35TTRALBALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228872-A1 | NANOPARTICLE-CONTAINING FILM, LIGHT-EMITTING ELEMENT, PRODUCTION METHOD FOR NANOPARTICLE-CONTAINING FILM | SHARP KABUSHIKI KAISHA (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228872-A1 | NANOPARTICLE-CONTAINING FILM, LIGHT-EMITTING ELEMENT, PRODUCTION METHOD FOR NANOPARTICLE-CONTAINING FILM | SHARP KABUSHIKI KAISHA (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228872-A1 | NANOPARTICLE-CONTAINING FILM, LIGHT-EMITTING ELEMENT, PRODUCTION METHOD FOR NANOPARTICLE-CONTAINING FILM | SHARP KABUSHIKI KAISHA (JP) | 2024-07-11 | — | — | US | disclosed |
| EP-3676252-B1 | DERIVATIVES AND COMPOSITION OF QUINOLINE AND NAPHTHYRIDINE | CHULABHORN FOUND (TH) | 2023-11-29 | — | — | EP | disclosed |
| WO-2022254601-A1 | NANOPARTICLE-CONTAINING FILM, LIGHT-EMITTING ELEMENT, PRODUCTION METHOD FOR NANOPARTICLE-CONTAINING FILM | シャープ株式会社 | 2022-12-08 | — | — | WO | disclosed |
| US-10889566-B2 | Derivatives and composition of quinoline and naphthyridine | CHULABHORN FOUNDATION (TH) | 2021-01-12 | — | — | US | disclosed |
| US-20200223820-A1 | DERIVATIVES AND COMPOSITION OF QUINOLINE AND NAPHTHYRIDINE | CHULABHORN FOUNDATION (TH) | 2020-07-16 | — | — | US | disclosed |
| EP-3184171-B1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2019-03-20 | — | — | EP | disclosed |
| EP-3184171-A1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | Chevron Phillips Chemical Company LP (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-2519532-B1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2017-03-08 | — | — | EP | disclosed |
| WO-2011002407-A1 | NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA | ASTRAZENECA AB (SE) | 2011-01-06 | — | — | WO | disclosed |
| US-7259229-B2 | Electroactive fluorene polymers having perfluoralkyl groups, process for preparing such polymers and devices made with such polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-08-21 | — | — | US | disclosed |
| US-7259229-B2 | Electroactive fluorene polymers having perfluoralkyl groups, process for preparing such polymers and devices made with such polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-08-21 | — | — | US | disclosed |
| US-7230070-B2 | Electroactive fluorene copolymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-06-12 | — | — | US | disclosed |
| US-7220820-B2 | Electroactive fluorene copolymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-22 | — | — | US | disclosed |
| US-7214763-B2 | Electroactive fluorene copolymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-08 | — | — | US | disclosed |
| US-7211643-B2 | Electroactive fluorene copolymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-01 | — | — | US | disclosed |
| US-7183365-B2 | Electroactive fluorene polymers having perfluoroalkyl groups, process for preparing such polymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-27 | — | — | US | disclosed |
| US-7183366-B2 | Aromatic copolymers from dihalofluorene compounds and another dihalo- or diborono- aromatic monomers; organic electroluminescent polymers for use in light-emitting diodes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-27 | — | — | US | disclosed |
| WO-2007020502-A2 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | PHARMACIA & UPJOHN COMPANY LLC (US) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10889566-B2 | Derivatives and composition of quinoline and naphthyridine | MCL1, TOP1, NQO2 | GPR35 4308/4885AR 2555/4885TTR 4204/4885 |
| US-20200223820-A1 | DERIVATIVES AND COMPOSITION OF QUINOLINE AND NAPHTHYRIDINE | C1R, CBR3, CBR1 | GPR35 2239/4885AR 532/4885TTR 4061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.